论文部分内容阅读
目的:探究分析对输卵管妊娠患者采取氨甲蝶吟配伍米非酮进行治疗的临床效果。方法:选取我院2012年10月-2013年11月收治的63例输卵管妊娠患者作为临床研究对象,对所有患者给予氨甲蝶吟配伍米非酮进行治疗,对其治疗效果进行观察对比。结果治疗成功60例,治疗成功率为95.2%;患者的血β-HCG下降不超过300mIU/mL,无一例患者出现阴道出血症状;患者的β-HCG恢复到正常范围;患者的住院时间为9-20d,平均住院时间为14d;治疗过程中无一例患者出现不良反应。结论:对输卵管妊娠患者采取氨甲蝶吟配伍米非酮进行治疗,能够有效提高治疗有效率,降低不良反应,值得临床应用推广。
Objective: To investigate the clinical efficacy of methotrexate in combination with mifepristone in patients with tubal pregnancy. Methods: 63 patients with tubal pregnancy admitted to our hospital from October 2012 to November 2013 were enrolled in this study. All patients were treated with methotrexate and mifepristone, and their therapeutic effects were observed and compared. Results 60 cases were successfully treated, the success rate was 95.2%. The decline of blood β-HCG in patients was no more than 300mIU / mL. None of the patients had symptoms of vaginal bleeding. The patient’s β-HCG returned to the normal range. The hospitalization time was 9 -20d, the average length of hospital stay was 14d; no adverse reactions occurred in one patient in the course of treatment. Conclusion: The treatment of tubal pregnancy with methotrexate mifepristone can effectively improve the treatment efficiency, reduce adverse reactions, it is worth promoting the clinical application.